A Phase I, Randomized, Double- Blind, Placebo- Controlled, Single-center Study, to Assess the Safety, Tolerability and Pharmacokinetics of AZD4451 Following Single Ascending Oral Dose Administration in Healthy Subjects

Trial Profile

A Phase I, Randomized, Double- Blind, Placebo- Controlled, Single-center Study, to Assess the Safety, Tolerability and Pharmacokinetics of AZD4451 Following Single Ascending Oral Dose Administration in Healthy Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 29 Jul 2011

At a glance

  • Drugs AZD 4451 (Primary)
  • Indications Depression
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 29 Jul 2011 Actual end date (Apr 2011) added as reported by ClinicalTrials.gov.
    • 29 Jul 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 28 Oct 2010 Actual initiation date (August 2010) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top